- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 417/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 417/06
Total number of patents in this class: 1840
10-year publication summary
|
101
|
136
|
130
|
96
|
96
|
97
|
109
|
97
|
92
|
51
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2710 |
58 |
| Boehringer Ingelheim International GmbH | 4493 |
36 |
| Janssen Pharmaceutica N.V. | 3162 |
33 |
| Bristol-myers Squibb Company | 4751 |
26 |
| Achillion Pharmaceuticals, Inc. | 157 |
23 |
| BASF SE | 21308 |
19 |
| Merck Sharp & Dohme LLC | 3736 |
19 |
| F. Hoffmann-La Roche AG | 7819 |
17 |
| The Regents of the University of California | 20778 |
17 |
| Biogen MA Inc. | 938 |
16 |
| VALO Health, Inc. | 193 |
16 |
| Shionogi & Co., Ltd. | 880 |
15 |
| Syngenta Crop Protection AG | 6710 |
14 |
| Amgen Inc. | 4429 |
11 |
| Abbvie Inc. | 1824 |
11 |
| Syngenta Participations AG | 1516 |
10 |
| FUJIFILM Corporation | 30516 |
10 |
| Actelion Pharmaceuticals Ltd | 494 |
10 |
| Armagen, Inc. | 33 |
10 |
| Abbott Laboratories | 2251 |
9 |
| Other owners | 1460 |